MKI67 and central nervous system cancer: AQP4-KO significantly reduced Ki67 positivity (Ki67+) in rat glioma models (Figure S4 C, D, 4.4 ± 1.5% Vs 19.9 ± 3.8% p = 0.0007, n = 11, 9).